These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 13433378)
21. Pathogenesis of contrast-induced nephropathy: experimental and clinical observations with an emphasis on the role of osmolality. Rudnick MR; Goldfarb S Rev Cardiovasc Med; 2003; 4 Suppl 5():S28-33. PubMed ID: 14668707 [TBL] [Abstract][Full Text] [Related]
22. N-acetylcysteine for contrast nephropathy: more clinical science is required. Eddleston M; Goddard J; Bateman N Arch Intern Med; 2006 Aug 14-28; 166(15):1668-9; author reply 1669. PubMed ID: 16908804 [No Abstract] [Full Text] [Related]
24. Water for contrast-induced nephropathy? A thirst for knowledge. Pate GE; Webb JG J Invasive Cardiol; 2003 Dec; 15(12):703-5. PubMed ID: 14660822 [No Abstract] [Full Text] [Related]
25. Effects of contrast media on renal function in patients with cirrhosis: a prospective study. Guevara M; Fernández-Esparrach G; Alessandria C; Torre A; Terra C; Montañà X; Piera C; Alvarez ML; Jiménez W; Ginès P; Arroyo V Hepatology; 2004 Sep; 40(3):646-51. PubMed ID: 15349903 [TBL] [Abstract][Full Text] [Related]
27. A new animal model for testing renal tolerance of contrast agents. Krause W; Gilles T Invest Radiol; 2003 Nov; 38(11):704-11. PubMed ID: 14566180 [TBL] [Abstract][Full Text] [Related]
28. [Contrast-induced nephropathy after computer tomography. Hydration and adapted contrast media dosage for the best prophylaxis]. Haglund M; Hesselstrand R; Nyman U; Sterner G Lakartidningen; 2005 Oct 3-9; 102(40):2864-6, 2869-70. PubMed ID: 16255363 [No Abstract] [Full Text] [Related]
29. [Fundamentals on iodinated contrast media and adverse reactions]. Feltrin GP; Zandonà M; Borile V; Rettore C; Miotto D Radiol Med; 2004 Apr; 107(4 Suppl 1):8-31. PubMed ID: 15323318 [No Abstract] [Full Text] [Related]
30. Significant statistical heterogeneity in a meta-analysis of the usefulness of acetylcysteine for prevention of contrast nephropathy. Faddy SC Am J Cardiol; 2004 Aug; 94(3):414. PubMed ID: 15276125 [No Abstract] [Full Text] [Related]
31. Kidneys may be tougher than you thought. Nursing; 2008 Oct; 38(10):12. PubMed ID: 18812981 [No Abstract] [Full Text] [Related]
32. Preventing complications of radiographic contrast media: is there a role for dialysis? Rodby RA Semin Dial; 2007; 20(1):19-23. PubMed ID: 17244114 [TBL] [Abstract][Full Text] [Related]
33. Risk factors and therapy strategies for contrast-induced nephropathy. Toprak O; Cirit M Ren Fail; 2006; 28(5):365-81. PubMed ID: 16825085 [TBL] [Abstract][Full Text] [Related]
34. Safety update on the possible causal relationship between gadolinium-containing MRI agents and nephrogenic systemic fibrosis. Pedersen M J Magn Reson Imaging; 2007 May; 25(5):881-3. PubMed ID: 17457808 [No Abstract] [Full Text] [Related]
35. On the potential causal relationship between gadolinium-containing MRI agents and nephrogenic systemic fibrosis. Partain CL J Magn Reson Imaging; 2007 May; 25(5):879-80. PubMed ID: 17457806 [No Abstract] [Full Text] [Related]